Xu, K.

stent patient death stent thrombosis trial thrombosis id-tlr spirit randomized paclitaxel-eluting artery lesion everolimu 2- year rates stent system paclitaxel-eluting stents paclitaxel-eluting stents jacc treatment syndrome study 2 years infarction xience outcome artery lesions everolimus-eluting cohort artery disease ef ficacy analysis drug-eluting table event ratio randomized trials finite revascularization intervention hazard cad cohorts planer stent type system eluting evaluation everolimus-eluting stents october –15 safety angina research consortium syndrome acuity hazard ratios stemi 0.01 figure ͻ0.0001 disease baseline boston scienti fic follow-up characteristic stone research ficacy abbreviation value target spirit trials bare-metal stents abbott 30 days scienti fidence interval signi curve boston reduction cardiol diameter